Wei Cao
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS Research and Interventions
- Virology top 2%
- HIV Research and Treatment
Papers in
- Virology 24
- HIV Research and Treatment 24
-
- COVID-19 Clinical Research Studies 11
- HIV/AIDS Research and Interventions 8
- SARS-CoV-2 and COVID-19 Research 4
- HIV/AIDS drug development and treatment 3
- Co-authors
- Taisheng Li (48 shared papers)Ling Lin (3 shared papers)Lianfeng Lu (13 shared papers)Jean‐Pierre Routy (12 shared papers)Vikram Mehraj (9 shared papers)Xiaosheng Liu (14 shared papers)Yang Han (20 shared papers)Evelyn Hsieh (5 shared papers)
- Journals
- BMC Infectious Diseases (7 papers)Frontiers in Immunology (6 papers)Emerging Microbes & Infections (3 papers)Journal of the International AIDS Society (3 papers)Aging (3 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Wei Cao
63 papers receiving 4.8k citations
Wei Cao's Hit Papers
Peers
Comparison fields: 5 of 125
- Infectious Diseases 2.7k
- Virology 453
- Internal Medicine 146
- Neurology 445
- Rheumatology 322
Countries citing papers authored by Wei Cao
This map shows the geographic impact of Wei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cao more than expected).
Fields of papers citing papers by Wei Cao
This network shows the impact of papers produced by Wei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cao. The network helps show where Wei Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Hit paper breakdown → | 2020 | 1742 |
| 2 | 2020 | 711 | |
| 3 | 2020 | 332 | |
| 4 | 2020 | 263 | |
| 5 | 2015 | 179 | |
| 6 | 2020 | 158 | |
| 7 | 2020 | 149 | |
| 8 | 2016 | 148 | |
| 9 | HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies Hit paper breakdown → | 2021 | 133 |
| 10 | 2020 | 126 | |
| 11 | 2020 | 124 | |
| 12 | 2016 | 89 | |
| 13 | 2020 | 88 | |
| 14 | 2020 | 73 | |
| 15 | 2020 | 65 | |
| 16 | 2015 | 59 | |
| 17 | Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation. | 2016 | 55 |
| 18 | 2020 | 55 | |
| 19 | 2020 | 48 | |
| 20 | 2021 | 24 |
About Wei Cao
Wei Cao is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Nephrology and Rheumatology, having authored 67 papers that have together received 5k indexed citations. Recurring topics across this work include HIV Research and Treatment (24 papers), COVID-19 Clinical Research Studies (11 papers), HIV/AIDS Research and Interventions (8 papers), HIV-related health complications and treatments (7 papers), Hepatitis B Virus Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), HIV/AIDS drug development and treatment (3 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Infectious Diseases (2.7k citations), Virology (453 citations), Internal Medicine (146 citations), Neurology (445 citations) and Rheumatology (322 citations). Wei Cao has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Taisheng Li, Ling Lin, Lianfeng Lu, Jean‐Pierre Routy, Vikram Mehraj, Xiaosheng Liu, Yang Han, Evelyn Hsieh, Kishanda Vyboh and Ke Hong. Their work appears in journals such as BMC Infectious Diseases, Frontiers in Immunology, Emerging Microbes & Infections, Journal of the International AIDS Society and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.